High Levels of Specific Antibodies Associated with Worsening Lung Function in Systemic Sclerosis Patients
A recent study showed that worsening symptoms of lung fibrosis in systemic sclerosis patients is linked to high levels of antibodies against the chemokine receptors Cxcr3 and Cxcr4. The results were revealed at the 4th Systemic Sclerosis World Congress held in Lisbon, Portugal, Feb. 18-20 in the presentation “Antibodies against chemokine…